What is the most important information I should know about methylphenidate transdermal?
Do not use
methylphenidate if you have used an MAO inhibitor such as
isocarboxazid (
Marplan),
tranylcypromine (
Parnate),
phenelzine (
Nardil),
rasagiline (
Azilect), or
selegiline (
Eldepryl,
Emsam) within the past 14 days.
Do not use this medication if you are allergic to methylphenidate or if you have
glaucoma, tics (
muscle twitches) or
Tourette's syndrome, or severe anxiety, tension, or agitation
(methylphenidate can make these symptoms worse).
Methylphenidate may be habit-forming. Keep track of how many patches have been
used from each new package you receive. Methylphenidate is a
drug of abuse and you should be
aware if any person in the household is using this medicine improperly or without a prescription.
Children using this medication should be warned never to remove the skin patch and
place it onto another person. Serious side effects may result.
What is methylphenidate transdermal?
Methylphenidate is a central nervous system stimulant. In affects chemicals in the brain
and nerves that contribute to hyperactivity and impulse control.
Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD).
Methylphenidate may also be used for other purposes not listed in this medication guide.
What should I discuss with my health care provider before using methylphenidate transdermal?
Do not use methylphenidate if you have used an MAO inhibitor such as
isocarboxazid (Marplan), tranylcypromine (Parnate), phenelzine (Nardil), rasagiline (Azilect), or
selegiline (Eldepryl, Emsam) within the past 14 days.
Do not use this medication if you are allergic to methylphenidate or if you
have:
-
glaucoma;
-
a personal or family history of tics (muscle twitches) or
Tourette's syndrome;
-
severe anxiety, tension, or agitation (methylphenidate can
make these symptoms worse); or
-
if you have ever had a skin reaction when using any type of
adhesive bandage or transdermal skin patch.
Some stimulants have caused sudden death in children and
adolescents with serious
heart problems or congenital heart defects.
Before using methylphenidate, tell your doctor if you are allergic to any drugs, or if you
have:
If you have any of these conditions, you may need a dose adjustment
or special tests to safely use this medication.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell
your doctor if you are
pregnant or plan to become pregnant during treatment.
It is not known whether methylphenidate passes into breast milk or if it could harm a
nursing baby. Do not use this medication without telling your doctor if you are
breast-feeding a
baby.
Long-term use of methylphenidate can slow a child's growth. Tell your doctor if the child
using this medication is not growing or gaining weight properly.
Do not use methylphenidate transdermal on a child younger than 6 years old without
the advice of a doctor.
Print
Email
Drug Info Tools
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
